Variant · Snv
MAX NM_002382.5(MAX):c.179G>A (p.Arg60Gln)
CI-VAR-00166366Explore in graph →p.Arg60GlnNM_002382.5:c.179G>AClinVar 958620 rs2063106020
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 958620 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications | 1 | Hereditary pheochromocytoma and paraganglioma; MAX-associated Macrocephaly and Polydactyly syndrome; Polydactyly-macrocephaly syndrome; Immature ovarian teratoma; Neuroblastoma; Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype; Diffuse midline glioma, H3 K27M-mutant; MAX-related disorder | germline/somatic | 6 | Dec 23, 2025 | clinvar |